XML 60 R49.htm IDEA: XBRL DOCUMENT v3.22.1
Stockholders' Equity - Stock-based Compensation (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended
Dec. 31, 2020
Mar. 31, 2022
Mar. 31, 2021
Mar. 31, 2022
Mar. 31, 2021
Stock-based Compensation          
Stock-based compensation expense   $ 6,898 $ 7,565 $ 20,986 $ 19,386
RSU          
Stock-based Compensation          
Unrecognized compensation cost   $ 20,300   $ 20,300  
Weighted-average period       1 year 9 months 18 days  
Shares          
Nonvested at the beginning of the period (in shares)       435,925  
Granted (in shares)       334,435  
Vested (in shares)       (335,099)  
Forfeited (in shares)       (4,542)  
Nonvested at the end of the period (in shares)   430,719   430,719  
Weighted-Average Fair Value          
Nonvested at the beginning of the period (in dollars per share)       $ 84.16  
Granted (in dollars per share)       90.31  
Vested (in dollars per share)       82.66  
Forfeited (in dollars per share)       84.21  
Nonvested at the end of the period (in dollars per share)   $ 90.11   $ 90.11  
Stock Options          
Stock-based Compensation          
Unrecognized compensation cost   $ 700   $ 700  
Weighted-average period       2 years 2 months 12 days  
Number of Options          
Outstanding at the beginning of the period (in shares)       255,220  
Granted (in shares)       22,954  
Exercised (in shares)       (164,612)  
Expired or forfeited (in shares)       (834)  
Outstanding at the end of the period (in shares)   112,728   112,728  
Exercisable at the end of the period (in shares)   72,371   72,371  
Weighted Average Exercise Price          
Outstanding at the beginning of the period (in dollars per share)       $ 50.24  
Granted (in dollars per share)       96.38  
Exercised (in dollars per share)       34.61  
Expired or forfeited (in dollars per share)       71.83  
Outstanding at the end of the period (in dollars per share)   $ 82.30   82.30  
Exercisable at the end of the period (in dollars per share)   $ 76.69   $ 76.69  
Weighted-Average Remaining Contractual Term          
Outstanding at the end of the period       6 years 4 months 24 days  
Exercisable at the end of the period       4 years 10 months 24 days  
Aggregate Intrinsic Value          
Outstanding at the end of the period   $ 816   $ 816  
Exercisable at the end of the period   $ 780   $ 780  
Performance-based restricted stock units          
Shares          
Granted (in shares)       96,620 136,242
Performance-based restricted stock units | Minimum          
Weighted-Average Fair Value          
Payout as a percentage of the original number of shares awarded or units awarded, which are converted into shares of the Company's common stock         0.00%
Performance-based restricted stock units | Maximum          
Weighted-Average Fair Value          
Payout as a percentage of the original number of shares awarded or units awarded, which are converted into shares of the Company's common stock       376.00%  
OSI Plans          
Stock-based Compensation          
Shares available for grant   1,400,000   1,400,000  
Weighted-Average Fair Value          
Additional maximum number of shares of common stock which may be issued 1,650,000        
Increase in maximum number of shares authorized under share based compensation plan 7,100,000        
OSI Plans | RSU          
Weighted-Average Fair Value          
Number of shares available for grant reduced for each award granted       1.87  
Number of shares available for grant increased for each award forfeited and returned       1.87  
Cost of goods sold          
Stock-based Compensation          
Stock-based compensation expense   $ 205 199 $ 616 $ 571
Selling, general and administrative          
Stock-based Compensation          
Stock-based compensation expense   6,567 7,223 19,977 18,391
Research and development          
Stock-based Compensation          
Stock-based compensation expense   $ 126 $ 143 $ 393 $ 424